Delcath Systems competitorsClear all

Delcath Systems's top competitors include OncoStem Diagnostics, CollPlant, Bio-Path Holdings and Corcept Therapeutics.
Delcath Systems
Delcath Systems
Delcath Systems is a specialty pharmaceutical and medical device company focused on oncology.
OncoStem Diagnostics
OncoStem Diagnostics
OncoStem Diagnostics is a diagnostic oncology company focused on discovering and developing novel tests for improved treatment planning.
CollPlant
CollPlant
CollPlant is a regenerative medicine company focused on 3D bioprinting of tissues and organs.
Bio-Path Holdings
Bio-Path Holdings
Bio-Path Holdings is a clinical and preclinical stage oncology focused antisense drug development company.
Corcept Therapeutics
Corcept Therapeutics
Corcept Therapeutics is a pharmaceutical company which discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders.
Founding Date
Founding Date
1988
Founding Date
2011
Founding Date
1981
Founding Date
2007
Founding Date
1998
Type
Type
Public
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
New York, US HQ
Galway, IE
Queensbury, US
Locations
Bengaluru, IN HQ
Locations
Ness Ziona, IL HQ
New York, US
Locations
Bellaire, US HQ
Locations
Menlo Park, US HQ
Employees
Employees
437% decrease
Employees
21
Employees
39
Employees
811% decrease
Employees
16622% increase
Valuation ($)
Valuation ($)
1 m
Valuation ($)
N/A
Valuation ($)
21.8 m
Valuation ($)
66.3 k
Valuation ($)
1.2 b
Twitter followers
Twitter followers
487
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
117
Alexa Website Rank
Alexa Website Rank
894835
Alexa Website Rank
N/A
Alexa Website Rank
751172
Alexa Website Rank
1520286
Alexa Website Rank
1121653

Financial

Revenue (est.)
Revenue (est.)
$3.4m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
$1m (FY, 2018)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$5.2m (FY, 2018)
Net income
Net income
($19.2m) (FY, 2018)
Net income
N/A
Net income
N/A
Net income
($8.6m) (FY, 2018)
Net income
$75.4m (FY, 2018)

Funding

Total funding raised
Total funding raised
$ 42m
Total funding raised
$ 7m
Total funding raised
N/A
Total funding raised
$ 2.3m
Total funding raised
$ 80.1m
For sources of this data, please see the company profile

View company profiles

OncoStem Diagnostics
HQ
Bengaluru, IN
Employees
21

OncoStem Diagnostics is a diagnostic oncology company focused on discovering and developing novel tests for improved treatment planning.

View company
CollPlant
HQ
Ness Ziona, IL
Employees
39

CollPlant is a regenerative medicine company focused on 3D bioprinting of tissues and organs.

View company
Bio-Path Holdings
HQ
Bellaire, US
Employees
8↓ 11% decrease

Bio-Path Holdings is a clinical and preclinical stage oncology focused antisense drug development company.

View company
Corcept Therapeutics
HQ
Menlo Park, US
Employees
166↑ 22% increase

Corcept Therapeutics is a pharmaceutical company which discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders.

View company